In this work, we examined the biological effects of SB431542, a TGF-β signaling inhibitor that specifically targets TGFBR1 [33,34,35], on various aspects of tumorigenesis in three GC cell lines: AGS, SNU-1, and KATO III. The gene discussed is TGFB1; the disease is gastric cancer.